Zu "133099-07-7" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Darifenacin hydrobromide
Artikelnummer: TGM-T1534-100mg
Description: Darifenacin hydrobromide (UK-88525) is a selective muscarinic receptor antagonist used to treat urinary incontinence and overactive bladder syndrome. Target: AChR. Smiles: c1cccc(c1)C(c1ccccc1)([C@H]1CN(CC1)CCc1cc2c(cc1)OCC2)C(=O)N.Br. References: Hegde SS, et al. Br J Pharmacol, 1997, 120(8), 1409-1418.
| Schlagworte: | UK-88525, Darifenacin HBr |
| Anwendung: | Targets muscarinic acetylcholine receptor M3 (CHRM3) |
| CAS | 133099-07-7 |
| MW: | 505.45 D |
ab 31,00 €
Darifenacin (hydrobromide)
Artikelnummer: Cay14424-10
Darifenacin is an antagonist of M3 muscarinic acetylcholine receptors (mAChRs, Ki = 0.76 nM). It is selective for M3 over M1, M2, M4, and M5 mAChRs (Kis = 7.08, 44.67, 45.71, and 9.33 nM, respectively). Darifenacin selectively inhibits contractions in isolated guinea pig ileum, bladder, and trachea (pA2s = 9.44,...
| Schlagworte: | UK 88525-04, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-alpha,alpha-diphenyl-3-pyrrolidineacetamide, monohydrobromide |
| Anwendung: | Muscarinic receptor antagonist |
| CAS | 133099-07-7 |
| MW: | 507.5 D |
ab 94,00 €
Darifenacin
Artikelnummer: LKT-D0169.10
| Anwendung: | Muscarinic acetylcholine receptor M3 antagonist |
| CAS | 133099-07-7 |
| MW: | 507,46 D |
ab 104,00 €
